Cargando…
Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox — United States, May 22–October 10, 2022
Autores principales: | Kriss, Jennifer L., Boersma, Peter M., Martin, Emalee, Reed, Kirsten, Adjemian, Jennifer, Smith, Nathaniel, Carter, Rosalind J., Tan, Kathrine R., Srinivasan, Arunkumar, McGarvey, Sunanda, McGehee, Jennifer, Henderson, Danielle, Aleshire, Noah, Gundlapalli, Adi V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620573/ https://www.ncbi.nlm.nih.gov/pubmed/36301741 http://dx.doi.org/10.15585/mmwr.mm7143e2 |
Ejemplares similares
-
Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022
por: Payne, Amanda B., et al.
Publicado: (2022) -
JYNNEOS Vaccination Coverage Among Persons at Risk for Mpox — United States, May 22, 2022–January 31, 2023
por: Owens, Lauren E., et al.
Publicado: (2023) -
Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose — 32 U.S. Jurisdictions, July 31–September 3, 2022
por: Payne, Amanda B., et al.
Publicado: (2022) -
Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak — United States, May 22–October 21, 2022
por: Duffy, Jonathan, et al.
Publicado: (2022) -
FDA's authorized “JYNNEOS” vaccine for counteracting monkeypox global public health emergency; an update – Correspondence
por: Sah, Ranjit, et al.
Publicado: (2022)